Puma Biotechnology Valuation
| PBYI Stock | USD 6.48 0.05 0.78% |
At this time, the company appears to be overvalued. Puma Biotechnology holds a recent Real Value of $5.16 per share. The prevailing price of the company is $6.48. Our model determines the value of Puma Biotechnology from analyzing the company fundamentals such as Operating Margin of 0.18 %, return on equity of 0.4, and Shares Outstanding of 50.39 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Puma Biotechnology's price fluctuation is relatively risky at this time. Calculation of the real value of Puma Biotechnology is based on 3 months time horizon. Increasing Puma Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Puma Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Puma Stock. However, Puma Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.48 | Real 5.16 | Hype 6.48 |
The intrinsic value of Puma Biotechnology's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Puma Biotechnology's stock price.
Estimating the potential upside or downside of Puma Biotechnology helps investors to forecast how Puma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Puma Biotechnology more accurately as focusing exclusively on Puma Biotechnology's fundamentals will not take into account other important factors: About Puma Biotechnology Valuation
An absolute valuation paradigm, as applied to Puma Stock, attempts to find the value of Puma Biotechnology based on its fundamental and basic technical indicators. By analyzing Puma Biotechnology's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Puma Biotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Puma Biotechnology. We calculate exposure to Puma Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Puma Biotechnology's related companies.Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company was founded in 2010 and is headquartered in Los Angeles, California. Puma Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.
Puma Biotechnology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.1 M | |
| Quarterly Earnings Growth Y O Y | -0.585 | |
| Forward Price Earnings | 3.459 |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |